Skip to main content

Table 1 Transition probability and utility for the 55-year-old cohort

From: Cost-effectiveness analysis of advanced radiotherapy techniques for post-mastectomy breast cancer patients

Parameters Years Value (%) (range) References
Probability
Local Recurrence 0–5 6.5 [22]
6–10 1.84
11–15 0.325
NED to metastasis 0–5 18.1 [23]
6–10 9.2
11–15 5.68
Metastasis to death 0–5 25.9 [18]
6–15 15.6
Normal death 56–60 (age) 3.2 [30]
61–65 (age) 4.7
66–70 (age) 5.8
Death due to lung toxicity 11–15 0.49 [25]
Death due to heart toxicity 11–15 2.6 [25]
Death due to CL breast toxicity 11–15 21.7 [22]
SOC PMRT cardiac toxicity 11–15 5.84 [12]
SOC PMRT CL breast cancer 6–15 1.0 [26]
SOC PMRT lung cancer 11–15 4.4 [27]
Utility
 Cardiac toxicity 11–15 0.85 (0.8–0.9) [35]
 CL breast cancer 11–15 0.803 (0.708–0.816) [43]
 Lung cancer 11–15 0.72 (0.57–0.87) [43, 44]
 Recurrence 0–15 0.85 [18]
 NED to metastasis 0–15 0.62 [18]
  1. NED: no evidence of. CL breast: contralateral breast
\